Summary 20
Mycoplasma hyopneumoniae, the causative agent of porcine enzootic pneumonia, colonises the 21 respiratory cilia of affected swine causing significant economic losses to swine production 22 worldwide. Heparin is known to inhibit adherence of M. hyopneumoniae to porcine epithelial 23 cilia. M. hyopneumoniae cells bind heparin but the identity of the heparin-binding proteins is 24
limited. Proteomic analysis of M. hyopneumoniae lysates identified 27 kDa (P27), 110 kDa 25 (P110) and 52 kDa (P52) proteins representing different regions of a 159 kDa (P159) protein 26 derived from mhp494. These cleavage fragments were surface located and present at all growth 27 stages. Following purification of 4 recombinant proteins spanning P159 (F1 P159 , F2 P159 , F3 P159 , 28 and F4 P159 ), only F3 P159 and F4 P159 bound heparin in a dose-dependent manner (Kd values 142.37 29 + 22.01 nM; 75.37 + 7.34 nM respectively). Scanning electron microscopic studies showed M.
Introduction 38
Mycoplasma hyopneumoniae, the etiological agent of enzootic pneumonia (EP), ranks as one of 39 the most economically significant diseases affecting swine production worldwide. The initial 40 event in colonization of the respiratory tract by M. hyopneumoniae is binding to respiratory cilia 41 (Blanchard et al., 1992; Mebus and Underdahl, 1977; Tajima and Yagihashi, 1982) . 42
Colonisation disrupts the mucociliary escalator through ciliostasis, loss of cilia, and epithelial 43 cell death (DeBey and Ross, 1994) . Acute inflammation of airways surrounding the site of 44 infection leads to epithelial hyperplasia and infiltration of the lamina propria by inflammatory 45 cells composed largely of neutrophils and mononuclear cells (Livingston et al., 1972) . Disease 46 resolution occurs only after a prolonged period (if at all) and once infected, swine remain 47 recalcitrant to reinfection (Kobisch et al., 1993) . Most cases of EP are chronic, and are often 48 complicated by secondary bacterial infections which exacerbate morbidity and mortality 49 (Ciprian et al., 1988) . M. hyopneumoniae also plays a major role in the porcine respiratory 50 disease complex in countries where infections with porcine respiratory and reproductive 51 syndrome virus complicate respiratory disease pathology (Thacker et al., 2000) . Collectively, 52
these observations indicate that losses in swine production due to this pathogen are likely to be 53 considerably underestimated. 54
Genome sequence information for several strains of M. hyopneumoniae has 55 facilitated proteomic studies and provided insight into families of molecules likely to play a role 56 in the disease process (Djordjevic et al., 2004; Minion et al., 2004; Vasconcelos et al., 2005) . 57
These advances are significant given that overall poor growth on agar surfaces coupled with a 58 lack of development of genetic tools to selectively mutate target genes has for many years 59 hampered efforts to identify molecules that play fundamental roles in pathogenesis (Minion, 60 2002). The cilium adhesin, P97 is the only cell surface adhesin that has been extensively 61 characterized in M. hyopneumoniae (Hsu and Minion, 1998; Minion et al., 2000) . P97 is 62 1A) with apparent molecular masses of 27 (P27), 52 (P52) and 110 (P110) kDa that represented 113 different regions spanning P159. To confirm the identity of the P159 fragments, 2-D 114 immunoblots of whole cell lysates of M. hyopneumoniae probed with a pool of antisera raised to 115 recombinant fragments F1 P159 -F4 P159 spanning P159 (see fig. 1C ) identified P159 fragments 116 shown in Fig. 1 (data not shown) . TMpred analysis 117 (www.ch.embnet.org/software/TMPRED_form.html) of P159 identified a single, putative 118 transmembrane region (score 2150) between amino acids 9-29 (Fig. 1B) . N-terminal sequence 119 analysis of P27 identified a peptide sequence corresponding to the first 7 amino acids 120 (MKKQIRN) of P159. Assuming P159 is a surface antigen (see later), this data suggests that the 121 transmembrane domain is not removed when the P159 preprotein is secreted to the cell surface. 122
Based on peptide mass mapping and N-terminal sequence analyses, P27 (observed pI 123 ~10) spans between amino acids 1-219 of the P159 sequence and cleavage at amino acid 220 124 would generate a protein fragment with a predicted mass of 24.5 kDa and a pI of 9.12 (Fig. 1B) . 125
Peptide mass matches of protein spots representing P52 and P110 spanned amino acids 978-126 1387 and 303-841 respectively (Fig. 1B) indicating that a cleavage event occurred between 127 amino acids 220-302 and between amino acids 842-977. To generate the P110 fragment, 128 cleavage events at amino acids 220 and 977 would generate a protein with a mass of 84.8 kDa 129
(pI of 6.28); cleavage at amino acids 303 and 841 would generate a peptide of 60.5 kDa (pI of 130 8.81). Protein spots representing P110 migrate with a pI between 6-6.5 suggesting that two 131 cleavage events probably occurred near amino acids 220 and 977. In either case, P110 has a 132 predicted mass ranging between 61 and 85 kDa indicating that this protein fragment migrates 133 aberrantly during SDS-PAGE. Amino acids 736-977 representing the predicted C-terminal 134 region of P110 are enriched in acidic residues (predicted pI of 5.01) and P159 fragments such as 135 P110 that span this region are expected to migrate with a more acidic pI compared to P27 and 136 P52 (pI 8.85). The presence of this region in P110 is likely to contribute to its aberrant migration 137 during SDS-PAGE. Assuming the first cleavage scenario is correct, P52 would span amino acids 138 977-1410 generating a protein with a predicted mass of 49 kDa. This is largely consistent with 139 the size and pI of P52 shown in Fig. 1A . Attempts to generate N-terminal sequence by Edman 140 degradation for P110 and P52 cleavage fragments were unsuccessful. Collectively, these data 141 suggest that P159 is rapidly processed during secretion to the cell surface (see later). 142
143

Purification and western blot analysis of P159 fragments 144
To examine the function(s) of regions within P159, four non-overlapping regions spanning the 145 entire molecule (Fig. 1C) coli typically resulted in an extremely poor protein yield and/or multiple translation products 152 presumably due to the high A+T content of mycoplasmal genes (Notarnicola et al., 1990) . 153
Attempts to clone and express the entire p159 gene into E. coli were unsuccessful. 154
Rabbit antisera raised separately to purified recombinant fragments F1 P159 -F4 P159 (Fig. 155 1C) were used to further investigate the post-translational cleavage pattern of P159 and to 156 determine their cellular location. Antiserum raised against F1 P159 (which spans P27) reacted 157 strongly with purified recombinant F1 P159 (Fig. 2 , panel A lane 2) but reacted poorly with P27 in 158 cell lysates of M. hyopneumoniae (Fig. 2, panel A, lane 1) . Although the poly-histidine tag 159 engineered into the N-terminus will contribute to the increased size of F1 P159 compared to P27, it 160 is unlikely to account for the 4 kDa difference in apparent mass of these two proteins. Of note, 161 the N-terminal 22-kDa cleavage fragment of the cilium adhesin P97 was also not easily detected 162 by immunoblotting (Djordjevic et al., 2004) . These data suggest that small cleavage fragments 163 containing intact transmembrane domains may bind poorly to PVDF membrane. As expected 164 both F2 P159 and F3 P159 antisera (which span P110) identified P110 (Fig. 2, panel B and C, lane 165 1). However these sera also detected a second protein with a predicted mass of approximately 68 166 kDa (P68) which probably represents an additional cleavage product of P159 so far undetected 167 in our proteomic analyses (see also Fig. 2 The higher mass form of F4 P159 was also recognized by commercial anti-poly-histidine antisera 174 further supporting this interpretation (data not shown). Whether this multimeric form of P52 175 plays a role in the biology of M. hyopneumoniae remains unknown. 176
To examine the immunoblot profile of P159 during different stages of growth in vitro, 177 synchronised cultures of M. hyopneumoniae collected between 8 h (early log phase) and 72 h 178 (late stationary phase) post-inoculation were reacted with a pool of F1 P159 -F4 P159 antisera. A 179 consistent pattern of three strongly staining fragments of masses 52, 68, and 110 kDa 180 (representing P52, P68 and P110) were detected at all time points suggesting that P159 is 181 processed in an identical fashion during early log (8 h), mid-log (16-28 h) and stationary phases 182 (40-72 h) of growth in vitro ( Fig. 2 panel E) . The P159 pre-protein was not detected suggesting 183 that it is rapidly processed. Immunoblot profiles of whole cell lysates representing different 184 strains of M. hyopneumoniae, when reacted with a pool of anti F1 P159 -F4 P159 , showed similar yet 185 distinct patterns suggesting that strain-specific cleavage events occur (Fig. 2F) . 186
187
Trypsin sensitivity and immuno-electron microscopy analysis of P159 188
To determine if P159 cleavage fragments are surface accessible, freshly cultured M. 189 hyopneumoniae strain 232 cells were exposed to concentrations of trypsin ranging from 0-150 190 μg/ml. Exposure of intact M. hyopneumoniae cells to trypsin concentrations from 0.1-3 μg/ml 191 showed a gradual loss of P68 and P110; these two proteins being almost completely digested at a 192 trypsin concentration of 10 μg/ml. P52 was the most resilient fragment and was detectable at a 193 trypsin concentration of 10 μg/ml but completely degraded with 50 μg/ml. There was no 194 evidence of any P159 cleavage fragment at trypsin concentrations above 50 μg/ml (Fig. 3A) . concentrations up to 300 μg/ml (data not shown; Djordjevic et al., 2004) . 202
To confirm the surface location of P159 fragments, immuno-electron microscopy was 203 conducted using F1 P159 -F4 P159 antisera. F2 P159 and F4 P159 antisera clearly showed that P159 204 fragments P110 and/or P68 and P52 recognized by these antisera reside on the surface of M. 205 hyopneumoniae strain 232 ( Fig. 3C and 3E ). Control sera collected prior to immunisation with 206 recombinant fragments reacted poorly with M. hyopneumoniae cells (Fig. 3B and 3D ). We were 207 unable to generate reliable images using antisera raised against F1 P159 and F3 P159 proteins 208 because of unacceptable levels of gold labeling with preimmune sera (data not shown). The kinetics of binding biotinylated heparin by F3 P159 and F4 P159 was examined in more 238 detail. At concentrations between 1-250 μg/ml, heparin profoundly affected the ability of F3 P159 239 and F4 P159 to bind biotinylated heparin with concentrations > 500 μg/ml effectively blocking 240 binding (Fig. 6A) . Non-linear regression with one-site competition determined the 50% 241 inhibitory concentration (IC 50 ) for F3 P159 and F4 P159 to be 52.92 + 1.03 μg/ml and 66.63 + 1.02 242 μg/ml, respectively. Various glycosaminoglycans were tested for their ability to inhibit the 243 binding of F3 P159 and F4 P159 to biotinylated heparin ( Fig. 6B and C (Zielinski et al., 1990) . In our 254 study we examined the ability of M. hyopneumoniae strain J cells to interact with PK15 cell 255 monolayers by scanning electron microscopy. We showed that M. hyopneumoniae adheres 256 intimately to the surface of PK15 cells with the mycoplasma often seen closely associated with 257 microvilli on the surface of the monolayers (Fig. 7A) . were pre-incubated with heparin they poorly bound to PK15 cell monolayers ( Fig. 10C and D) . 284
The effect of pre-incubating F2 P159 -and F4 P159 -coated latex beads separately with heparin and 285 with excess F2 P159 and F4 P159 proteins on their ability to adhere to and enter PK15 cells is 286 summarized in Fig. 10D . Pre-incubation of F2 P159 -and F4 P159 -coated latex beads with a 287 saturating concentration of heparin inhibited binding to PK15 cells by 89 and 64% respectively 288 (Fig. 10D) . Significantly, heparin completely abolished entry of F2 P159 -and F4 P159 -coated latex 289 beads into PK15 cells (Fig. 10D ). Pre-incubation of F4 P159--coated latex beads with excess 290 F4 P159 inhibited the binding and entry of F4 P159 -coated latex beads by 71% and 67% 291 respectively and displayed the greatest ability of all the P159 recombinant proteins to inhibit the 292 binding and invasion of latex beads coated with recombinant P159 proteins (Fig. 10D) . These observations bear a striking resemblance to those reported for the cilium adhesin 313 P97 (mhp183); i) the P126 pre-protein is barely detectable by immunoblot and is extensively 314 cleaved, generating fragments ranging in mass from 20-120 kDa (Djordjevic et al., 2004) , ii) the 315 N-terminal cleavage fragment P22 contains the only significant transmembrane domain found in 316 the molecule, yet many of the cilium adhesin cleavage fragments are present on the cell surface 317 and iii) processing is strain-specific. These observations suggest that P159 and P126 pre-proteins 318 are processed via the same pathway. Although the surface topography of M. hyopneumoniae is 319 poorly understood we have now provided evidence that three high-mass surface proteins of M. 320 hyopneumoniae P159 (this study; mhp494), P97 (mhp183) and P102 (mhp182) (Djordjevic et 321 al., 2004) are cleaved with fragments residing on the cell surface. No evidence for proteolytic 322 processing was reported for two well characterized surface lipoproteins with masses of 65 kDa 323 (Kim et al., 1990 ) and 46 kDa (Futo et al., 1995) . These data suggest that surface molecules 324 secreted via type II but not type I secretory pathways may be targeted for further proteolytic 325 processing in M. hyopneumoniae but additional studies are needed to rigorously test this 326 hypothesis. The identity and specificity of the corresponding protease(s) that cleave these 327 proteins remains unknown. However, bioinformatic analysis of the M. hyopneumoniae genome 328 identified five proteins with aminopeptidase signatures (mhp209, Map; mhp462, PepA; mhp520, 329 PepF; mhp680, PepP; and mhp656, Gcp) and a further two with serine protease signatures 330 (mhp287 and mhp292). One or several of these are suspected of playing a role in surface protein 331 processing. 332
BlastP analyses showed that mhp494 is a novel molecule with discrete regions showing 333 limited homology to proteins found in Mycoplasma conjunctivae and M. hyopneumoniae. 334
Specifically, two regions spanning amino acids 1004-1406 and 2-200 of P159 showed 22% 335 identity (41% similarity) and 25% identity (46% similarity) respectively with LppT from 336
Mycoplasma conjunctivae (Belloy et al., 2003) . lppT is the second gene in a two-gene operon 337 with lppS which was reported to be an adhesin in this species (Belloy et al., 2003) . Furthermore, 338 amino acids 1026-1165 displayed 26% identity (48% similarity) with mhp182 (P102) and amino 339 acids 10-209 and 17-191 showed 28% identity (51% similarity) and 28% identity (44% 340 similarity) with P102 paralogs mhp272 and mhp384 respectively. 341
Different strains of M. hyopneumoniae have been shown to adhere to PK15 cell 342 monolayers (Zielinski et al., 1990) Fucoidan, a sulfated polysaccharide of non-mammalian origin, inhibited the interaction 399 between heparin and F3 P159 and F4 P159 . It is generally the case that heparin-binding proteins also 400 interact with fucoidan due to its high sulfate density and branched, comb-like structure, which 401 contrasts with the linear structure of mammalian glycosaminoglycans (Patankar et al., 1993) . 402
Chondroitin sulfate A and B and mucin did not competitively inhibit the ability of heparin to 403 bind P159 fragments F3 P159 and F4 P159 ; heparan sulfate, a less sulfated version of heparin, only 404 slightly inhibited these interactions. Chondroitin sulfate B is similar in structure to heparin and 405 heparan sulfate in that it contains a backbone of iduronate residues yet failed to act as a 406 competitive inhibitor. Collectively, these observations suggest that the degree of sulfation is a 407 key component in F3 P159 and F4 P159 binding heparin. 408
In conclusion, evidence presented here indicates that P159 is a proteolytically processed, by 20 cm polyacrylamide gel. Second-dimension electrophoresis was carried out at 5 o C using 3 453 mA/gel for 2 h followed by 20 mA/gel until the bromophenol blue dye had run to the end of the 454 gel. Gels were fixed in 40% methanol and 10% acetic acid for 1 h, stained overnight in Sypro 455
Ruby (Molecular Probes, Eugene, Oregon) and images acquired using a Molecular Imager Fx 456 apparatus (Bio-Rad Laboratories, Hercules, California). Gels were then double stained in 457
Coomassie blue G-250. Protein spots were excised from gels using a sterile scalpel blade and 458 placed into 96-well V bottom trays (Greiner Bio-One, Longwood, Florida). The methods used 459 for post-separation analyses are as described previously (Djordjevic et al., 2004) . A list of 460 monoisotopic peaks corresponding to the mass of generated tryptic peptides was used to search a 461 modified translated version of the M. hyopneumoniae genome (Minion et al., 2004) . N-terminal 462
Edman sequencing was performed as previously described (Nouwens et al., 2000) . 463
464
Molecular analyses, cloning and expression. 465
Plasmid DNA was prepared using a plasmid MidiPreparation kit (Qiagen, Alameda, California) 466 as per manufacturer's instructions. DNA sequence analysis was performed using the Sanger 467 method. PCR was carried out using a DTCS Quickstart Master Mix (Beckman Coulter, 468
Fullerton, California), according to the manufacturer's instructions and analysed using a 469 CEQ8000 Genetic Analyser (Beckman Coulter, Fullerton, California). Both pQE-9 specific 470 primers and internal primers were used to initiate sequencing of DNA and were purchased from 471
Sigma-Aldrich (Sydney, Australia). Hexahistidyl P159 fusion proteins were constructed using 472 pPCR-Script (Stratagene, La Jolla, California) and pQE-9 (Qiagen, Alameda, California) cloning 473 vectors. Primer sequences used to amplify each of the four fragments are given in Table 1 were blocked by incubation with 200 μl of 10 mg/ml BSA in PBS for 1 h at room temperature. 506
The efficiency of particle loading was verified by fluorescence-activated cell sorter analysis with 507 anti-F1 P159 -F4 P159 rabbit serum (results not shown). Beads were washed and the volume adjusted 508 to 2.5 ml with Dulbecco modified Eagle medium (Invitrogen, Karlsruhe, Germany) with HEPES 509 and 1% foetal calf serum. PK15 cells (American type culture collection certified cell line 33) 510
were seeded on 12-mm-diamater glass coverslips (Nunc, Wiesbaden, Germany) placed on the 511 bottom of 24-well tissue culture plates (Nunc, Wiesbaden, Germany) at 1.5 x 10 5 cells per well 512 and allowed to grow to semi-confluent monolayers at 37 o C in a 5% CO 2 atmosphere. After 513 addition of 250 μl of the bead suspension, the cells were incubated for 2, 4, 7 and 22 h at 37 o C in 514 a 5% CO 2 atmosphere. Cells were washed three times with PBS to remove unbound beads. 515
Cells were either processed for scanning electron microscopy (Molinari et al., 1997) or for 516 double immunofluorescence microscopy as described below. Further studies were conducted 517 pre-incubating the latex beads with a saturating concentration of heparin (500 μg/ml), purified 518 F1 P159 , F2 P159 , F3 P159 , and F4 P159 proteins (1 μg each), or anti-F1 P159 -F4 P159 sera (25 μg) 519 separately for 1h at 37 o C in a 5% CO 2 atmosphere before addition to the PK15 cells. 520 PK15 cells were seeded on 12-mm-diamater glass coverslips placed on the bottom of 24-521 well tissue culture plates at 1.5 x 10 5 cells per well and allowed to grow to semi-confluent 522 monolayers at 37 o C in a 5% CO 2 atmosphere. A 5 ml fresh M. hyopneumoniae (strain J, ATCC 523 27715) culture was centrifuged at 10,000 g and resuspended in 100 μl of Dulbecco modified 524
Eagle medium (Invitrogen, Karlsruhe, Germany) with HEPES and 1% foetal calf serum. 10 μl of 525 M. hyopneumoniae suspension per well was added to 0.5 ml of confluent PK15 cells and 526 incubated at 37 o C in a 5% CO 2 atmosphere for 2 h. The wells were then prepared for electron 527 microscopy as reported previously (Molinari et al., 1997) . Additional experiments where M. 528 hyopneumoniae was pre-incubated with a saturating concentration of heparin (500 μg/ml), 529 purified F1 P159 , F2 P159 , F3 P159 , and F4 P159 proteins (1 μg each), or anti-F1 P159 -F4 P159 sera (25 μg) 530 separately for 1h at 37 o C in a 5% CO 2 atmosphere before addition to the PK15 cells were 531 conducted. 532 533
Antisera, immunotechniques and microscopy. 534
Antisera to each fragment of P159 were generated by subcutaneous immunization of New 535
Zealand White rabbits with hexahistidyl-tagged products purified by nickel-affinity 536 chromatography. Pre-immune sera were collected prior to immunization for the preparation of 537 control serum. Rabbits were then each immunized on two occasions 21 days apart using 538
Freund's incomplete adjuvant (Sigma-Aldrich, St. Louis, Missouri), and immune responses 539 monitored by immunoblotting. Rabbits were euthanased, and serum collected as described 540 previously (Wilton et al., 1998) . Horse radish peroxidase-conjugated sheep anti-rabbit 541 immunoglobulin antibodies were purchased commercially (Chemicon, Temecula, California). 542
M. hyopneumoniae whole cell protein preparations and purified hexahistidyl F1 P159 -543 F4 P159 proteins along with M. hyopneumoniae growth assay samples were subjected to 544 electrophoresis on 12% SDS-PAGE gels as described previously (Laemmli, 1970) . After 545 electrophoresis, proteins were electrophoretically transferred onto polyvinylidene difluoride 546 membrane using a Hoefer Scientific TE Series Transphor Electrophoresis Unit (Hoefer, San 547
Francisco, California) as described previously (Burnette, 1981) . Immunoblotting experiments 548
were performed with rabbit polyclonal antibodies raised against F1 P159 -F4 P159 , either separately 549 or pooled. Peroxidase conjugated sheep anti-rabbit was used as the secondary antibody and 550 detected using diaminobenzidine (DAB; Sigma-Aldrich, St. Louis, Missouri). 551 PK15 cells (after incubation with the coated latex beads) were washed with PBS and 552 then fixed by the addition of 0.5 ml/well of pre-cooled fixation buffer (1% paraformaldehyde in 553 PBS), the tray was placed on ice for 1 h and then stored at recombinant proteins were allowed to adsorb overnight at room temperature. The wells were 597 then blocked with 100 μl aliquots of PBS containing 2% (w/v) skim milk for 1 h at room 598 temperature. Biotinylated heparin (Sigma-Aldrich, St. Louis, Missouri) in PBS containing 1% 599 skim milk was next applied to the wells in 100 μl aliquots and incubated for 1.5 h at room 600 temperature. After 3 washes with 0.05% (v/v) Tween20 in PBS, bound biotinylated heparin was 601 detected using 100 μl aliquots of peroxidase conjugated streptavidin (Roche, Basel, Switzerland) 602 diluted 1:3000 with a 1 h incubation at room temperature. The wells were washed as above prior 603 to the addition of substrate solution (100 μl) containing 0.55 mg/ml 2,2'-azino-bis(3-604 ethylebenzthiazoline-6-sulfonic acid) diammonium salt (ABTS; Sigma-Aldrich, St. Louis, 605
Missouri) in 0.1 M citrate, 0.2 M phosphate, pH 4.2, containing 0.03% (v/v) hydrogen peroxide. 606
The absorbance of the product formed was measured at 414 nm using a Multiskan Ascent 607 ELISA plate reader (Thermo Labsystems, Franklin, Massachusetts). In other experiments, a 608 competitive binding assay was used in which unlabeled glycosaminoglycans; heparin, fucoidan, 609 heparan sulfate, mucin, chondroitin sulphate A and chondroitin sulfate B (all from Sigma-610 Aldrich, St. Louis, Missouri) were pre-incubated with biotinylated heparin for 15 min before the 611 addition of 100 μl aliquots of the mixture to coated and blocked wells. Control experiments 612
showed that none of the P159 fragments could bind to streptavidin-peroxidase or the ABTS 613 solution, establishing that the heparin binding is not an artifact of binding to a compound used in 614 the detection system. Graph construction and non-linear regression with one-site binding and 615 one-site competition analysis was performed using GraphPad Prism version 4 (GraphPad 616
Software, San Diego, California). 617
A cell pellet of E. coli M15 [pREP4] cells (Qiagen, Alameda, California) containing 618 the pQE-9 F1 P159 -F4 P159 plasmids from a 300 ml culture were re-suspended in a solution of 50 619 mM DTT, 2% triton X-100, 1 mg/ml lysozyme. The suspension was subjected to sonication and 620 then centrifuged at 16, 000 g for 15 min at 10 o C and the supernatant was applied to a 7.5 ml 621 heparin-agarose column (Sigma-Aldrich, St. Louis, Missouri) that had been pre-equilibrated 622 with 0.01 M Tris-HCl (pH 7.6). The column was washed with 45 ml 0.01 M Tris-HCl (pH 7.6) 623 and bound proteins eluted at a flow rate of 1 ml/min with a linear 0-0.5 M NaCl gradient in 0.01 624 M Tris-HCl (pH 7.6). The peak fractions (from the wash and elution's) at 280 nm absorbance 625 were subjected to electrophoresis on 12% SDS-PAGE gels as described previously (Laemmli, 626 1970) . After electrophoresis, proteins were electrophoretically transferred onto polyvinylidene 627 difluoride membrane using a Hoefer Scientific TE Series Transphor Electrophoresis Unit 628 (Hoefer, San Francisco, California) as described previously (Burnette, 1981 
